• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Influence of novel oral anticoagulants on anticoagulation care management.

作者信息

Janzic Andrej, Kos Mitja

机构信息

.

出版信息

Acta Pharm. 2017 Sep 1;67(3):397-406. doi: 10.1515/acph-2017-0030.

DOI:10.1515/acph-2017-0030
PMID:28858833
Abstract

Anticoagulation treatment was recently improved by the introduction of novel oral anticoagulants (NOACs). Using a combination of qualitative and quantitative methods, this study explores the effects of the introduction of NOACs on anticoagulation care in Slovenia. Face-to-face interviews with key stakeholders revealed evolvement and challenges of anticoagulation care from different perspectives. Obtained information was further explored through the analysis of nationwide data of drug prescriptions and realization of health care services. Simplified management of anticoagulation treatment with NOACs and their high penetration expanded the capacity of anticoagulation clinics, and consequentially the treated population increased by more than 50 % in the last 5 years. The main challenge concerned the expenditures for medicines, which increased approximately 10 times in just a few years. At the same time, the anticoagulation clinics and their core organisation were not affected, which is not expected to change, since they are vital in delivering high-quality care.

摘要

相似文献

1
Influence of novel oral anticoagulants on anticoagulation care management.
Acta Pharm. 2017 Sep 1;67(3):397-406. doi: 10.1515/acph-2017-0030.
2
Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.心房颤动患者口服抗凝治疗的依从性。聚焦于非维生素K拮抗剂口服抗凝药。
Thromb Haemost. 2017 Jan 26;117(2):209-218. doi: 10.1160/TH16-10-0757. Epub 2016 Nov 10.
3
Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control.新型口服抗凝药用于房颤患者卒中预防的成本效益:取决于华法林抗凝控制的质量
Pharmacoeconomics. 2015 Apr;33(4):395-408. doi: 10.1007/s40273-014-0246-7.
4
Incorporating Comprehensive Management of Direct Oral Anticoagulants into Anticoagulation Clinics.将直接口服抗凝剂的综合管理纳入抗凝门诊。
Pharmacotherapy. 2017 Oct;37(10):1284-1297. doi: 10.1002/phar.1991. Epub 2017 Sep 6.
5
Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).慢性非瓣膜性心房颤动患者在现实生活实践中口服抗凝管理的过程和质量描述性分析:抗凝管理国际研究(ISAM)
J Thromb Thrombolysis. 2007 Apr;23(2):83-91. doi: 10.1007/s11239-006-9022-7.
6
Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.非维生素K拮抗剂口服抗凝药时代之前心房颤动患者的抗栓治疗:心房颤动患者长期口服抗栓治疗全球注册研究(GLORIA-AF)第一阶段队列研究
Europace. 2016 Sep;18(9):1308-18. doi: 10.1093/europace/euw073. Epub 2016 Jun 21.
7
Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.新型口服抗凝药(NOACs)的处方量已超过华法林:探究医生如何选择抗凝治疗药物。
Eur J Clin Pharmacol. 2018 Mar;74(3):323-330. doi: 10.1007/s00228-017-2374-4. Epub 2017 Nov 17.
8
Reimagining Anticoagulation Clinics in the Era of Direct Oral Anticoagulants.直接口服抗凝剂时代抗凝门诊的重塑
Circ Cardiovasc Qual Outcomes. 2016 Mar;9(2):182-5. doi: 10.1161/CIRCOUTCOMES.115.002366. Epub 2016 Mar 1.
9
Expanding anticoagulation management services to include direct oral anticoagulants.扩大抗凝管理服务范围,纳入直接口服抗凝剂。
J Thromb Thrombolysis. 2018 Feb;45(2):274-280. doi: 10.1007/s11239-017-1602-1.
10
Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.直接口服抗凝药物治疗方案的处方实践比较。
Am J Cardiovasc Drugs. 2017 Dec;17(6):475-479. doi: 10.1007/s40256-017-0243-2.